Skip to content

Author

Xin-Chi Luan

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Fluoropyrimidine-associated gastrointestinal toxicity: pharmacovigilance reporting signals and in vitro evidence of epithelial injury, barrier impairment, and inflammatory responses

Experimental evidence is provided that fluoropyrimidine exposure is associated with epithelial injury, impaired barrier function, and epithelial inflammatory responses, and the reporting signals do not estimate event frequency in treated populations or establish causality.

Xin-Chi Luan, Xiao-Ran Li, Xiao-Xuan Li et al. · 0 citations
Open access Sep 2026

Multinational pharmacovigilance assessment of drug-associated esophageal ulceration and perforation: evidence from FAERS, JADER, and Canada Vigilance

Drug-associated esophageal ulceration and perforation are uncommon but clinically serious adverse events. This study characterized post-marketing reporting patterns for these events across three spontaneous reporting systems. Reports from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS), Jap...

Li-Hua Zhang, Xin-Chi Luan, Cai-Qi Liu et al. · 0 citations
Oct 2026

Mcu upregulation triggers mitochondrial oxidative stress and cardiomyocyte injury after myocardial infarction yet is suppressed by Fto and Ythdf2 in an m6A-dependent manner.

It is demonstrated that elevated Mcu is positively associated with MI risk; excess Mcu triggers mitochondrial calcium overload, ROS buildup, mitochondrial membrane potential loss and respiratory chain damage to facilitate cardiomyocyte damage, whereas Mcu knockdown alleviate these pathological alterations.

Ruo-Lan Chen, Xue-Zhe Wang, Lu-Ning Qin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.